Clinical Trial Update: Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population [Phase 3]

View source ↗

Summary

A Phase 3 trial of a cancer vaccine for Asian patients with stage III unresectable non-small cell lung cancer was terminated, and the results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Unspecified cancer vaccine

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2016-08-02